Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein

Lisa R. Tannock, Maria C. De Beer, Ailing Ji, Preetha Shridas, Victoria P. Noffsinger, Laura Den Hartigh, Alan Chait, Frederick C. De Beer, Nancy R. Webb

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Serum amyloid A (SAA) is a family of acute-phase reactants. Plasma levels of human SAA1/SAA2 (mouse SAA1.1/2.1) can increase ≥1,000-fold during an acute-phase response. Mice, but not humans, express a third relatively understudied SAA isoform, SAA3. We investigated whether mouse SAA3 is an HDL-associated acute-phase SAA. Quantitative RT- PCR with isoform-specific primers indicated that SAA3 and SAA1.1/2.1 are induced similarly in livers (2,500-fold vs. 6,000-fold, respectively) and fat (400-fold vs. 100-fold, respectively) of lipopolysaccharide (LPS)-injected mice. In situ hybridization demonstrated that all three SAAs are produced by hepatocytes. All three SAA isoforms were detected in plasma of LPS-injected mice, although SAA3 levels were 20% of SAA1.1/2.1 levels. Fast protein LC analyses indicated that virtually all of SAA1.1/2.1 eluted with HDL, whereas 15% of SAA3 was lipid poor/free. After density gradient ultracentrifugation, isoelectric focusing demonstrated that 100% of plasma SAA1.1 was recovered in HDL compared with only 50% of SAA2.1 and 10% of SAA3. Thus, SAA3 appears to be more loosely associated with HDL, resulting in lipid-poor/free SAA3. We conclude that SAA3 is a major hepatic acute-phase SAA in mice that May produce systemic effects during inflammation.

Original languageEnglish
Pages (from-to)339-347
Number of pages9
JournalJournal of Lipid Research
Volume59
Issue number2
DOIs
StatePublished - 2018

Bibliographical note

Funding Information:
This work was supported by the US Department of Veterans Affairs Awards CX000975 (L.R.T.) and CX000773 (N.R.W.) and National Institutes of Health Grants HL134731 (N.R.W., F.C.D.B.), HL092969 (A.C.), AT007177 (L.d.H.), and P20 GM103527 (support for used cores). Mass spectrometric analysis was performed at the University of Kentucky, Proteomics Core Facility. This core facility is supported in part by funds from the Office of the Vice President for Research. The content of this study is solely the responsibility of the authors and does not represent the official views of the US Department of Veterans Affairs, the National Institutes of Health, or the United States Government.

Funding Information:
This work was supported by the US Department of Veterans Affairs Awards CX000975 (L.R.T.) and CX000773 (N.R.W.) and National Institutes of Health Grants HL134731 (N.R.W., F.C.D.B.), HL092969 (A.C.), AT007177 (L.d.H.), and P20 GM103527 (support for used cores). Mass spectrometric analysis was performed at the University of Kentucky, Proteomics Core Facility. This core facility is supported in part by funds from the Office of the Vice President for Research. The content of this study is solely the responsibility of the authors and does not represent the official views of the US Department of Veterans Affairs, the National Institutes of Health, or the United States Government. Manuscript received 25 September 2017 and in revised form 22 November 2017. Published, JLR Papers in Press, December 15, 2017 DOI https://doi.org/10.1194/jlr.M080887

Keywords

  • Animal models
  • Inflammation
  • Liver
  • Supplementary key words adipose tissue

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein'. Together they form a unique fingerprint.

Cite this